Anna Serefko
About
Anna Serefko is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Biological Psychiatry.
According to data from OpenAlex, Anna Serefko has authored 87 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 26 papers in Cellular and Molecular Neuroscience and 26 papers in Biological Psychiatry. Recurrent topics in Anna Serefko's work include Tryptophan and brain disorders (26 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Anna Serefko is often cited by papers focused on Tryptophan and brain disorders (26 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Anna Serefko collaborates with scholars based in Poland, Finland and Hungary. Anna Serefko's co-authors include Ewa Poleszak, Aleksandra Szopa, Piotr Właź, Katarzyna Socała, Urszula Doboszewska, Andrzej Wróbel, Marcin Włodarczyk, Jakub Fichna, Anna Zielińska and Monika Elżbieta Jach and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.
In The Last Decade
Anna Serefko
83 papers receiving 1.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anna Serefko Poland | 20 | 651 | 427 | 382 | 296 | 293 | 87 | 2.0k | ||
| Aleksandra Szopa Poland | 18 | 557 0.9× | 400 0.9× | 344 0.9× | 282 1.0× | 254 0.9× | 77 | 1.7k | ||
| Antônio Carlos Pinheiro de Oliveira Brazil | 31 | 854 1.3× | 380 0.9× | 533 1.4× | 540 1.8× | 605 2.1× | 88 | 2.9k | ||
| Katarzyna Socała Poland | 20 | 730 1.1× | 246 0.6× | 281 0.7× | 393 1.3× | 363 1.2× | 70 | 1.8k | ||
| Geanne Matos de Andrade Brazil | 32 | 649 1.0× | 245 0.6× | 350 0.9× | 406 1.4× | 453 1.5× | 80 | 2.8k | ||
| Urszula Doboszewska Poland | 20 | 569 0.9× | 334 0.8× | 148 0.4× | 279 0.9× | 318 1.1× | 45 | 1.5k | ||
| Ahmet Gürel Türkiye | 34 | 614 0.9× | 237 0.6× | 188 0.5× | 445 1.5× | 157 0.5× | 75 | 3.2k | ||
| Saravana Babu Chidambaram India | 29 | 1.2k 1.8× | 322 0.8× | 262 0.7× | 625 2.1× | 395 1.3× | 139 | 3.1k | ||
| Sadık Söğüt Türkiye | 30 | 566 0.9× | 333 0.8× | 226 0.6× | 363 1.2× | 158 0.5× | 56 | 3.0k | ||
| Claudia Cristiano Italy | 24 | 724 1.1× | 240 0.6× | 413 1.1× | 641 2.2× | 402 1.4× | 50 | 2.3k | ||
| Stefania Schiavone Italy | 28 | 831 1.3× | 711 1.7× | 339 0.9× | 676 2.3× | 371 1.3× | 73 | 3.2k |
Countries citing papers authored by Anna Serefko
Since
Specialization
Citations
This map shows the geographic impact of Anna Serefko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Serefko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Serefko more than expected).
Fields of papers citing papers by Anna Serefko
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anna Serefko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Serefko. The network helps show where Anna Serefko may publish in the future.
Co-authorship network of co-authors of Anna Serefko
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Serefko. A scholar is included among the top collaborators of Anna Serefko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Serefko. Anna Serefko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Widelski, Jarosław, et al.. (2025). Zebrafish as a Suitable Model for Utilizing the Bioactivity of Coumarins and Coumarin-Based Compounds. International Journal of Molecular Sciences. 26(4). 1444–1444.
2.
Herbet, Mariola, Jarosław Widelski, Marta Ostrowska-Leśko, et al.. (2025). Exploring the Toxicity and Therapeutic Potential of A. dahurica and A. pubescens in Zebrafish Larvae: Insights into Anxiety Treatment Mechanisms. International Journal of Molecular Sciences. 26(7). 2884–2884.
3.
Szopa, Aleksandra, et al.. (2024). Nutritional Quality Implications: Exploring the Impact of a Fatty Acid-Rich Diet on Central Nervous System Development. Nutrients. 16(7). 1093–1093.
4.
Serefko, Anna, Aleksandra Szopa, Piotr Dobrowolski, et al.. (2024). The Orexin OX2 Receptor‐Dependent Pathway Is Implicated in the Development of Overactive Bladder and Depression in Rats Exposed to Corticosterone. Neurourology and Urodynamics. 44(1). 229–244.
5.
Jach, Monika Elżbieta, Anna Serefko, Aleksandra Szopa, et al.. (2023). The Role of Probiotics and Their Metabolites in the Treatment of Depression. Molecules. 28(7). 3213–3213.
6.
Zapała, Łukasz, Piotr Zapała, Artur Wdowiak, et al.. (2023). The Cannabinoid Ligand Arachidonyl-2′-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model. International Journal of Molecular Sciences. 24(4). 3820–3820.
7.
Poleszak, Ewa, Joanna Listos, Bernadeta Szewczyk, et al.. (2023). The L‐arginine‐NO‐cGMP pathway mediates the locomotor activity alterations during the expression of sensitization to mephedrone in mice. Clinical and Experimental Pharmacology and Physiology. 50(8). 621–633.
8.
Walczak, Łucja Justyna, Aleksandra Szopa, Monika Pitucha, et al.. (2023). Newly synthesized derivatives with a thiosemicarbazide group reduce the viability of cancer cell lines. Acute toxicity assessment in Zebrafish (Danio rerio) early life stages. Toxicology in Vitro. 95. 105741–105741.
9.
Serefko, Anna, Ewa Poleszak, Aleksandra Szopa, et al.. (2021). Neurobehavioral properties of Cymbopogon essential oils and its components. Phytochemistry Reviews. 21(2). 327–338.
10.
Pieróg, Mateusz, Katarzyna Socała, Urszula Doboszewska, et al.. (2021). Effects of classic antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish. Toxicology and Applied Pharmacology. 415. 115429–115429.
11.
Pieróg, Mateusz, Katarzyna Socała, Urszula Doboszewska, et al.. (2021). Effects of new antiseizure drugs on seizure activity and anxiety-like behavior in adult zebrafish. Toxicology and Applied Pharmacology. 427. 115655–115655.
12.
Rafało-Ulińska, Anna, Ewa Poleszak, Aleksandra Szopa, et al.. (2020). Imipramine Influences Body Distribution of Supplemental Zinc Which May Enhance Antidepressant Action. Nutrients. 12(9). 2529–2529.
13.
Blicharski, Tomasz, et al.. (2019). Challenges in technology of bilayer and multi-layer tablets: a mini-review. SHILAP Revista de lepidopterología. 32(4). 229–235.
14.
Szopa, Aleksandra, Anna Serefko, Elżbieta Wyska, et al.. (2019). Agomelatine and tianeptine antidepressant activity in mice behavioral despair tests is enhanced by DMPX, a selective adenosine A2A receptor antagonist, but not DPCPX, a selective adenosine A1 receptor antagonist. Pharmacological Reports. 71(4). 676–681.
15.
Szopa, Aleksandra, Ewa Poleszak, Elżbieta Wyska, et al.. (2018). DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(12). 1361–1371.
16.
Poleszak, Ewa, Aleksandra Szopa, Elżbieta Wyska, et al.. (2015). Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacological Reports. 68(1). 56–61.
17.
Wróbel, Andrzej, Anna Serefko, Piotr Właź, & Ewa Poleszak. (2015). The effect of imipramine, ketamine, and zinc in the mouse model of depression. Metabolic Brain Disease. 30(6). 1379–1386.
18.
Właź, Piotr, Anna Serefko, Aleksandra Szopa, & Ewa Poleszak. (2015). The effect of an acute and 7-day administration of magnesium chloride on magnesium concentration in the serum, erythrocytes, and brain of rats. Pharmacological Reports. 68(2). 289–291.
19.
Serefko, Anna, Aleksandra Szopa, Piotr Właź, et al.. (2013). Magnesium in depression. Pharmacological Reports. 65(3). 547–554.
20.
Serefko, Anna & Anna Malm. (2009). Sensitivity of Candida albicans isolates to caspofungin – comparison of microdilution method and E-test procedure. Archives of Medical Science. 5(1). 23–27.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Aleksandra Szopa Breakdown of academic impact, for papers by Antônio Carlos Pinheiro de Oliveira Breakdown of academic impact, for papers by Katarzyna Socała Breakdown of academic impact, for papers by Geanne Matos de Andrade Breakdown of academic impact, for papers by Urszula Doboszewska Breakdown of academic impact, for papers by Ahmet Gürel Breakdown of academic impact, for papers by Saravana Babu Chidambaram Breakdown of academic impact, for papers by Sadık Söğüt Breakdown of academic impact, for papers by Claudia Cristiano Breakdown of academic impact, for papers by Stefania Schiavone